周四盘中,微创机器人-B(02252)股价大涨5.03%,引起市场广泛关注。这一涨幅很可能与公司旗下 "图迈单臂单孔腔镜手术机器人" 获得国家药品监督管理局注册批准有关。
图迈单臂单孔腔镜手术机器人是该公司研发的新一代手术机器人产品,通过单个小孔即可实施腹腔手术,创伤小、恢复快,大大提升了手术精准度和安全性。此次获批标志着该产品将正式进入市场销售阶段。
行业分析人士表示,图迈机器人的上市获批将进一步巩固微创机器人在手术机器人市场的领先地位,有利于公司扩大市场份额、提升竞争力。投资者对该公司的发展前景更加看好,从而推动股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.